Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating microRNAs as a biomarker to predict therapy efficacy in hepatitis C patients with different genotypes.

Microbial pathogenesis - 1 Nov 2017

Fan Zhicheng, Zhang Qiaoxin, Chen Huanzhu, He Ping, Li Yazhen, Si Mengya, Jiao Xiaoyang

Abstract excerpt

BACKGROUND: Hepatitis C virus (HCV) genotype exerts a major influence on therapeutic response; however, the underlying mechanisms remain unclear. The aim of the study is to investigate the circulating microRNAs as the biomarkers to predict the response to therapy in chronic hepatitisC patients (HepC) with different genotypes. METHODS: HepC patients were separated into 4 groups by genotype, healthy individuals...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Coinfection
Share to Exosomes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C

Share to MicroRNAs

Share to RNA, Viral

Share to Viral Load

Source

Identifiers

PMID: 28993299
DOI: 10.1016/j.micpath.2017.10.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating microRNAs as a biomarker to predict therapy efficacy in hepatitis C patients with different genotypes.PMID 28993299Read ↗

Severity of hepatitis C virus (genotype-3) infection positively correlates with circulating microRNA-122 in patients sera.Semantic proximity Read ↗

Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patientsSemantic proximity Read ↗

MicroRNA-122a as a non-invasive biomarker for HCV genotype 4-related hepatocellular carcinoma in Egyptian patientsSemantic proximity Read ↗

Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C.Semantic proximity Read ↗

Evaluation of miR-122 Serum Level and IFN-λ3 Genotypes in Patients with Chronic HCV and HCV-Infected Liver Transplant Candidate.Semantic proximity Read ↗

Circulating microRNAs as predictors of response to sofosbuvir + daclatasvir + ribavirin in in HCV genotype-4 Egyptian patients.Semantic proximity Read ↗

Circulating microRNA-122 in HCV Cirrhotic Patients with High Frequency of Genotype 3Semantic proximity Read ↗

Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected PatientsSemantic proximity Read ↗

Circulating microRNA-122 in HCV cirrhotic patients with high frequency of genotype 3.Semantic proximity Read ↗

MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.Semantic proximity Read ↗

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapySemantic proximity Read ↗

Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.